CFO transition
BioRestorative Therapies, Inc. CFO transition: Anna Skowron to succeed Katharyn Field
BioRestorative Therapies, Inc. reported in a Form 8-K filed September 2, 2026 that Anna Skowron will succeed Katharyn Field as Chief Financial Officer and Treasurer, effective August 27, 2026.
In the filing's words
Effective August 27, 2026, the Board appointed Anna Skowron as the Company’s Chief Financial Officer and Treasurer, serving as the Company’s principal financial officer and principal accounting officer on a non-employee, fractional basis through BPC Consulting Ltd.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | BioRestorative Therapies, Inc. (BRTX) |
|---|---|
| Event | Transition |
| Incoming | Anna Skowron |
| Outgoing | Katharyn Field |
| Title in the filing | Chief Financial Officer and Treasurer |
| Effective | August 27, 2026 |
| 8-K filed | September 2, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Principal, BPC Consulting Ltd. |
| SEC CIK | 0001505497 |
BioRestorative Therapies, Inc. reported this change in a Form 8-K, Item 5.02, filed September 2, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Anna Skowron? Send a correction with the primary source.